$BMY Recent News Earnings roundup: Cubist, Merck gain

New Post Public Reply Private Reply Replies (0) Message Board

May 2, 2014 at 9:38 AM

$BMY Recent News

Earnings roundup: Cubist, Merck gain as HCA, Bristol-Myers slide 11:48 a.m. April 29, 2014 - Russ Britt
Value trumps growth as investors pick Exxon over Tesla 10:48 a.m. April 29, 2014 - William L. Watts
Twitter, eBay, Sprint, Herbalife are stocks to watch 5:31 a.m. April 29, 2014 - Sue Chang
Market leaders energy, utilities face earnings gauntlet 11:17 a.m. April 28, 2014 - Wallace Witkowski
The market in a minute: Sell calls and puts 11:11 a.m. April 28, 2014 - The Trading Deck
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Market rookie Five Prime's shares surge on deal with Bristol-Myers 12:01 p.m. March 17, 2014 - Russ Britt
RadioShack sinks; J.C. Penney gains on S&P outlook hike 5:19 p.m. March 4, 2014 - Sue Chang
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment 5:01 p.m. March 4, 2014 - Russ Britt
Billionaire Stan Druckenmiller's recent moves 12:50 p.m. Feb. 24, 2014 - Insider Monkey
Feds, pharma rivals team up on Alzheimer's 3:32 p.m. Feb. 6, 2014 - Elizabeth O'Brien
Merck hits a new high as analyst sees opening for new cancer drug 12:16 p.m. Jan. 27, 2014 - Russ Britt
U.S. stocks tumble; Dow drops 318 points 6:29 p.m. Jan. 24, 2014 - Anora Mahmudova
Juniper buoyed by Jana stake; Herbalife loss grows 4:50 p.m. Jan. 24, 2014 - Sue Chang
U.S. stock futures trim losses ahead of market open 9:57 a.m. Jan. 24, 2014 - Barbara Kollmeyer
Beam, Honeywell, Procter & Gamble are stocks to watch 6:38 a.m. Jan. 24, 2014 - Sue Chang
AstraZeneca, Bristol-Myers Secure EU OK for Xigduo 3:44 a.m. Jan. 22, 2014 - MarketWatch.com
‘Sloppy’ market turns to consumer, tech earnings 9:01 a.m. Jan. 19, 2014 - Wallace Witkowski
America's best and most generous 401(k)s 3:30 p.m. Jan. 15, 2014 - Anne Tergesen

Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. Today - TheStreet.com
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Laggard 5:01 p.m. May 1, 2014 - TheStreet.com
Bristol-Myers Squibb's (BMY) CEO John Elicker on Q1 2014 Earnings - Call Transcript 12:26 p.m. April 30, 2014 - TheStreet.com
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala 10:37 a.m. April 30, 2014 - Seeking Alpha
6 Drugs That Could Move the Pharma Market 9:24 a.m. April 30, 2014 - Wall St. Cheat Sheet
Celgene Deal Chief Calls Big Pharma Gutless For Lack of Biotech M&A 4:26 p.m. April 29, 2014 - TheStreet.com
Bristol-Myers Squibb's CEO Discusses Q1 2014 Results - Earnings Call Transcript 3:04 p.m. April 29, 2014 - Seeking Alpha
Bristol-Myers Reports Higher Earnings, Biotech Buy 2:07 p.m. April 29, 2014 - The Wall Street Journal Interactive Edition
Why Bristol-Myers Squibb (BMY) Stock Is Down Today 12:44 p.m. April 29, 2014 - TheStreet.com
Bristol, Merck, Sanofi Report Soft Q1 Sales 11:15 a.m. April 29, 2014 - Investors Business Daily
6 Drugs That Could Move the Market 9:58 a.m. April 29, 2014 - Wall St. Cheat Sheet
10-Q: BRISTOL MYERS SQUIBB CO 9:51 a.m. April 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Bristol-Myers Squibb Company (BMY) Is Today's Pre-Market Laggard Stock 9:39 a.m. April 29, 2014 - TheStreet.com
Top 5 Responsible Corporations in the U.S. 9:22 a.m. April 29, 2014 - Wall St. Cheat Sheet
Bristol-Myers Squibb Company Discusses Q1 2014 Results (Webcast) 8:55 a.m. April 29, 2014 - Seeking Alpha
More on Bristol-Myers Q1: Buys iPierian for $175M up front 8:44 a.m. April 29, 2014 - Seeking Alpha
UPDATE: Bristol-Myers Posts Higher Q1 Profit 7:44 a.m. April 29, 2014 - benzinga.com
Bristol-Myers Squibb Acquires iPierian for $175M, Potential Milestone Payments of $550M 6:08 a.m. April 29, 2014 - benzinga.com
'Fast Money' Recap: The Problem With Growth Stocks 5:00 a.m. April 29, 2014 - TheStreet.com
AstraZeneca Chief Puts Cancer Drugs Ahead of Deals 9:12 p.m. April 28, 2014 - The Wall Street Journal Interactive Edition

Approvals from the European Commission and Release of Quarterly Financial Results - Analyst Notes on Merck, Johnson & Johnson, Bristol-Myers Squibb, Teva and AbbVie 8:00 a.m. Today - PR Newswire - PRF
Technical Recap on Pharma Equities -- Research on Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline 9:16 a.m. May 1, 2014 - PR Newswire - PRF
Philanthropic Leaders Pledge $170 Million to Support Veterans and Military Families 11:11 a.m. April 30, 2014 - GlobeNewswire
Are Exosomes the Next PD-1 in Cancer Research? 10:01 a.m. April 30, 2014 - ACCESSWIRE
Kimberly-Clark Ranks Among Top 20 on '100 Best Corporate Citizens' Survey For Sixth Straight Year 4:35 p.m. April 29, 2014 - PR Newswire - PRF
North America Contrast Media Injectors Market Outlook to 2020 11:51 a.m. April 29, 2014 - PR Newswire - PRF
Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 3:10 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb 2:09 p.m. April 25, 2014 - PR Newswire - PRF
Bristol-Myers Squibb Ranks First on 2014 Best Corporate Citizens List 1:01 p.m. April 24, 2014 - BusinessWire - BZX
Allied Minds Names Peter Dolan and Jeff Rohr to Board of Directors 8:04 a.m. April 24, 2014 - BusinessWire - BZX
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013 4:55 p.m. April 23, 2014 - PR Newswire - PRF
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth 1:05 p.m. April 23, 2014 - PR Newswire - PRF
North America Nuclear Imaging Equipment Market Outlook to 2020 12:48 p.m. April 23, 2014 - PR Newswire - PRF
North America Ultrasound Systems Market Outlook to 2020 12:36 p.m. April 23, 2014 - PR Newswire - PRF
Peregrine Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab and Ipilimumab (Yervoy(R)) in Advanced Melanoma 7:30 a.m. April 23, 2014 - Marketwire
Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement 7:00 p.m. April 22, 2014 - BusinessWire - BZX
Surveyed U.S. Physicians Expect Strong Uptake of Novel Oral Anticoagulants for the Treatment of VTE 11:30 a.m. April 17, 2014 - PR Newswire - PRF
FluoroPharma Appoints Dr. H. William Strauss, Internationally Recognized Expert in the Field of Cardiovascular Nuclear Medicine, to Chair the Scientific Advisory Board 7:27 a.m. April 14, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

American Lung Association's Bold $21M Research Investment

Pumping Life into Lung Health Research The American Lung Association (ALA) just announced a jaw-dropping $21 million investment this year into lung health research. That's right, while some are counting beans, ALA is diving headfirst into serious health challenges plaguing millions of Americans. They've pumped hundreds of millions in the past decade, totaling $193...

Service Pros Adds Windshield Repair to Lineup

Revving Up the Service Engine Alright, folks, buckle up because Service Pros Auto Glass, our local go-to for windshield replacements, is cranking up their game. They're stepping into the windshield repair arena across Florida and South Carolina, aiming to save you a buck and keep you safe behind the wheel. That's a double win if you ask me. A Closer Look at the Details...

BAILOR Welcomes Co-Founder Bob Bailor to Coach Academy

A New Chapter for a Seasoned Entrepreneur There's a certain irony in a seasoned business vet stepping into a new role at his own daughter's company, and that's exactly what's unfolding with the Bailors. Huntsville's own BAILOR isn't just another growth strategy company; it's the embodiment of a father-daughter dream team. After years as the ordinary head honcho, Bob...

AppLovin Faces Class Action Amid Model Concerns

AppLovin's Day in the Hot Seat Look, it's not every day you see a tech darling like AppLovin take such a nosedive, but that's what's on the plate right now. The company is staring down a securities class action lawsuit. It’s a bumpy ride for folks who parked their cash in AppLovin between February and August 2026, expecting high-flying returns based on big promises of...

Bravo Loans Bridge Gaps in Healthcare Real Estate

Mezzanine Financing: A Vital Tool for Healthcare Owners Bravo Property Trust is throwing a lifeline to operators in the healthcare sector and beyond with their mezzanine loans aiming right between the eyes of the financing gap. This isn't just some loan for fun. It's a full-on financial tool designed to give some breathing room to folks owning or operating skilled nursing...

Investors Face Nov 13 Deadline in ASTS Fraud Suit

AST SpaceMobile's Investor Woes: Legal Storm Brewing There's a storm brewing over at AST SpaceMobile, and it's catching investors right in the thick of it. We're talking about a class action lawsuit that’s accusing the folks at ASTS of pulling the wool over investors' eyes. If you've bought into ASTS between March 4, 2025, and July 15, 2026, you've got a decision to...

Lecanemab's New Data: What Investors Should Monitor

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Are Shareholder Interests at Risk in These Deals?

Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...

AstroRad Vest Makes Spaceflight History at Smithsonian

Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...

ACR Poker's $650K Mystery PKO Tournaments Heat Up

Final Countdown for ACR Poker’s Halloween Bash When it comes to poker, there might not be a better mix of tension and thrill than a big bounty tournament, and ACR Poker’s $650K Halloween Special Mystery PKOs are right in the thick of it. We’re down to the wire with just the final starting flights left, and the action’s ready to blow the lid off come November 1....